Neonatal herpes encephalitis caused by a virologically confirmed acyclovir-resistant herpes simplex virus 1 strain

Journal of Clinical Microbiology

Volumn 51, Issue 1, 2013, Pages 356-359

  Kakiuchi, Satsuki ^a,c   Nonoyama, Shigeaki ^b   Wakamatsu, Hajime ^b   Kogawa, Kazuhiro ^b   Wang, Lixin ^a   Kinoshita Yamaguchi, Hitomi ^a   Takayama Ito, Mutsuyo ^a   Lim, Chang Kweng ^a   Inoue, Naoki ^a   Mizuguchi, Masashi ^c   Igarashi, Takashi ^c   Saijo, Masayuki ^a,c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PLASMID VECTOR; THYMIDINE KINASE; VIDARABINE; VIRUS ANTIBODY; VIRUS DNA; VIRUS ENZYME;

AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; ANTIVIRAL RESISTANCE; ARTICLE; BACTERIUM CULTURE; BIRTH WEIGHT; BLISTER; BLOOD ANALYSIS; CASE REPORT; DRUG CEREBROSPINAL FLUID LEVEL; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAILURE TO THRIVE; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HOSPITAL ADMISSION; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; LETHARGY; LUMBAR PUNCTURE; MALE; MEDICAL HISTORY; NEUROIMAGING; NEWBORN; NEWBORN ASSESSMENT; NEWBORN INFECTION; PHYSICAL EXAMINATION; PLEOCYTOSIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SKIN CULTURE; THROAT CULTURE; TREATMENT RESPONSE; VAGINITIS; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VTK GENE;

ACYCLOVIR; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; ENCEPHALITIS, HERPES SIMPLEX; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PREGNANCY COMPLICATIONS, INFECTIOUS; SEQUENCE ANALYSIS, DNA; THYMIDINE KINASE;

HERPES; HUMAN HERPESVIRUS 1;

EID: 84871674964     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02247-12     Document Type: Article

References (20)

1. Kimura H, Shibata M, Kuzushima K, Nishikawa K, Nishiyama Y, Morishima T. 1990. Detection and direct typing of herpes simplex virus by polymerase chain reaction. Med. Microbiol. Immunol. 179:177-184. (Pubitemid 20343614)
2. Piret J, Boivin G. 2011. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob. Agents Chemother. 55:459-472.
3. Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford CA Jr. 1982. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J. Infect. Dis. 145:829-836. (Pubitemid 12088959)
4. Shiota T, Lixin W, Takayama-Ito M, Iizuka I, Ogata M, Tsuji M, Nishimura H, Taniguchi S, Morikawa S, Kurane I, Mizuguchi M, Saijo M. 2011. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay. Antiviral Res. 91:142-149.
5. Saijo M, Suzutani T, Itoh K, Hirano Y, Murono K, Nagamine M, Mizuta K, Niikura M, Morikawa S. 1999. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus. J. Med. Virol. 58:387-393. (Pubitemid 29326053)
6. Whitley RJ. 1993. Neonatal herpes simplex virus infections. J. Med. Virol. 1993(Suppl 1):13-21. (Pubitemid 23290478)
7. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Soong SJ, Kiell J, Lakeman FD, Whitley RJ. 2001. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 108:223-229.
8. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Weller S, Soong SJ, Kiell J, Lakeman FD, Whitley RJ. 2001. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108:230-238.
9. Levin MJ, Weinberg A, Leary JJ, Sarisky RT. 2001. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr. Infect. Dis. J. 20:1094-1097. (Pubitemid 33055088)
10. Nyquist AC, Rotbart HA, Cotton M, Robinson C, Weinberg A, Hayward AR, Berens RL, Levin MJ. 1994. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J. Pediatr. 124:967-971.
11. Oram RJ, Marcellino D, Strauss D, Gustafson E, Talarico CL, Root AK, Sharma PL, Thompson K, Fingeroth JD, Crumpacker C, Herold BC. 2000. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J. Infect. Dis. 181:1458-1461. (Pubitemid 30252555)
12. Evans JS, Lock KP, Levine BA, Champness JN, Sanderson MR, Summers WC, McLeish PJ, Buchan A. 1998. Herpesviral thymidine kinases: laxity and resistance by design. J. Gen. Virol. 79(Pt 9):2083-2092. (Pubitemid 28423401)
13. Kussmann-Gerber S, Kuonen O, Folkers G, Pilger BD, Scapozza L. 1998. Drug resistance of herpes simplex virus type 1 - structural considerations at the molecular level of the thymidine kinase. Eur. J. Biochem. 255:472-481. (Pubitemid 28340257)
14. Vogt J, Perozzo R, Pautsch A, Prota A, Schelling P, Pilger B, Folkers G, Scapozza L, Schulz GE. 2000. Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography. Proteins 41:545-553.
15. Schulte EC, Sauerbrei A, Hoffmann D, Zimmer C, Hemmer B, Muhlau M. 2010. Acyclovir resistance in herpes simplex encephalitis. Ann. Neurol. 67:830-833.
16. Chen Y, Scieux C, Garrait V, Socie G, Rocha V, Molina JM, Thouvenot D, Morfin F, Hocqueloux L, Garderet L, Esperou H, Selimi F, Devergie A, Leleu G, Aymard M, Morinet F, Gluckman E, Ribaud P. 2000. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin. Infect. Dis. 31:927-935. (Pubitemid 32299349)
17. Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, Palmer A, Sanchez PJ, Jacobs RF, Bradley JS, Robinson JL, Shelton M, Dennehy PH, Leach C, Rathore M, Abughali N, Wright P, Frenkel LM, Brady RC, Van Dyke R, Weiner LB, Guzman-Cottrill J, McCarthy CA, Griffin J, Jester P, Parker M, Lakeman FD, Kuo H, Lee CH, Cloud GA. 2011. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N. Engl. J. Med. 365:1284-1292.
18. Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, Jacobs R, Van Dyke R, Burchett S, Soong SJ, Lakeman A, Whitley R. 1996. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr. Infect. Dis. J. 15:247-254. (Pubitemid 26098476)
19. Kimberlin DW, Lakeman FD, Arvin AM, Prober CG, Corey L, Powell DA, Burchett SK, Jacobs RF, Starr SE, Whitley RJ. 1996. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis. 174:1162-1167. (Pubitemid 26393892)
20. Mejías A, Bustos R, Ardura MI, Ramirez C, Sanchez PJ. 2009. Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis. J. Perinatol. 29:290-296.